Solventum earnings were $1.4B for the trailing 12 months ending Mar 31, 2026, with 276.6% growth year over year. The latest SOLV earnings report on Mar 31, 2026 announced Q1 2026 earnings of $13.0M, down 79.4% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, SOLV reported annual earnings of $1.6B, with 224.8% growth.
SOLV past earnings growth
How has SOLV's earnings growth performed historically?
On SOLV's earnings call on Invalid Date, Solventum (NYSE: SOLV) reported Q1 2026 earnings per share (EPS) of $0.07, up 91.14% year over year. Total SOLV earnings for the quarter were $13.00 million. In the same quarter last year, Solventum's earnings per share (EPS) was $0.79.
As of the last Solventum earnings report, Solventum is currently profitable. Solventum's net profit (also called net income) for the twelve months ending Mar 31, 2026 was $1.43 billion, a 277.84% increase year over year.
What was SOLV's earnings growth in the past year?
As of Solventum's earnings date in Invalid Date, Solventum's earnings has grown 276.61% year over year. This is 194.01 percentage points higher than the US Health Information Services industry earnings growth rate of 82.6%. SOLV earnings in the past year totalled $1.43 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.